BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


May Archive 2005 - have your press release here?

Novagali Pharma launches Phase I clinical trial in oncology for its oral formulation of paclitaxel

The German Resource Center for Genome Research (RZPD) to co-operate with Austrian Insilico GmbH

Borean Pharma Granted United States Patent for Lead Therapeutic Candidate for Atherosclerosis

Borean Pharma Granted United States Patent for Lead Therapeutic Candidate for Atherosclerosis

Acolyte Biomedica Ltd Launches BacLite® Rapid MRSA Test - New high speed test promises to help prevent spread of MRS

Apollo Life Sciences to Raise $9.5 Million via ASX Listing

Ablynx and the National Research Council Canada Sign Collaborative Deal to Develop NanobodiesT for CNS Disorders

Research Borean Pharma appoints John Nieland as VP Preclinical

Survey Identifies Best Way to Reach Scientists Using Catalogs

Leading biomedical research center standardises genome sequencing operations on Genetix QPix2XT

Sir Brian Richards joins the Board of Lipoxen Technologies

Symphogen Appoints New Medical Advisory Board And Scientific Advisory Board Member

Prolysis Raises $9.9 Million To Fund Preclinical Development

IntegraGen Works With the Fondation Autisme to Create a DNA Sample Databank

Oxagen Limited Raises $59.8 Million in Series B Private Venture Capital Financing Led by MPM Capital

York Pharma plc Interim Results - Monday 23rd May 2005

Syncroscopy Auto-Montage Pro at the Natural History Museum - Rapidly Generates over 400 Accurate Images for Major Entomology Project

Morphochem provides novel lead compounds for further development from successful collaboration

Affitech AS in-licenses human oncology antibodies

Meditech Clinical Data Published In International Cancer Journal

Blue Membranes and Relisys Medical announce the closing of a worldwide licence and supply agreement for BlueM’s proprietary drug-delivery coating technology.

Santaris Pharma initiates Phase I/II multi-centre clinical trial in Chronic Lymphocytic Leukaemia

Bioinvent's Candidate Drug Against Hiv/Aids Approved To Enter Clinical Trials In UK

An novel approach to the combination of AFM with optical spectroscopy

Syngene New GeneGnome Range Offers One Click Imaging of any Chemiluminescent Blot

The SETsquared Partnership appoints Northbank Communications as PR consultants

LifeCycle Pharma Successfully Completes €15 Million Financing

Haptogen announce landmark collaboration with DaeWoong Pharmaceuticals to develop novel anti-infectives

Oxford Biomedica Presents Updated And Encouraging Trovax Phase Ii Results In Colorectal Cancer At The 2005 Asco Annual Meeting

Genetix launches QPDisplay - new automated phage display system

Agilent Technologies to open new scientific training center in Shanghai

Northbank Communications strengthens team with two promotions

Northbank Communications wins financial communications appointments for York Pharma and CeNeS Pharmaceuticals

Northbank Communications appoints Director of Finance and Operations

Applied Biosystems/MDS Sciex is the Top Supplier in the Mass Spectrometer Market

Dowpharma and Cytogen Agree to Develop PSMA Antibody for Treatment of Cancer

Peakdale collaborates with Dynamic Extractions on new purification technology

NiKem Research Srl and Hybrigenics SA Significantly Expand their Research Service Agreement in the Oncology Area

IDBS acquires DAT-LABTM and leads the way to the next generation ELN

York Pharma plc will be announcing its Interim Results for the six months ended 31 March 2005 on Monday May 23rd 2005.

Atugen Achieves Milestones on Schering Target Validation Agreement

OXFORD BIOMEDICA receives European patent for TroVax® covering 5T4 tumour antigen-targeted immunotherapy

IDS Ltd acquire Suomen Bioanalyytiikka Oy (SBA)

A NEW High Sensitivity, Multi-species Corticosterone EIA from IMMUNODIAGNOSTIC SYSTEMS LIMITED (IDS)

1,25-Dihydroxy Vitamin D EIA now available from IMMUNODIAGNOSTIC SYSTEMS LIMITED (IDS)

Northbank Communications boosts marketing communications team with the appointment of Sarah Jeffery as Account Director

Oxford Biomedica Presents Encouraging Preclinical Efficacy Data With Retinostat® In Age-Related Macular Degeneration

Synco Biopartners And Cobra Biomanufacturing Form Alliance To Manufacture Plasmid Dna For Phase III Trials And Commercial Supply

BSI Proteomics Introduces New Service-Structure Activity Relationships (SAR) by Nuclear Magnetic Resonance

MEDITECH TO PRESENT AT GLOBAL HEALTHCARE CONFERENCE, PARIS

TTP LabTech’s “hit-picker” can sample any well - PICK THE HITS WITH MOSQUITO® X1

Biomoda, Inc., an Invitro Diagnostics Company, Enters Into Agreement with Cytomyx, LLC a leader in translational medicine

Western invasion threatens Japanese pharma's survival

Novel combinations breathe life into COPD market

Positive Phase I Data for Neurotech’s NT- 501 Encapsulated Cell Delivery of Ciliary Neurotrophic Factor to Eyes of Patients with Retinitis Pigmentosa

ProImmune launches the new ProVETM MHC Pentamer Libraries

BioNewsCast Press Release Service 2005 Archive

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.